Omada Health is a virtual chronic care company that reaches patients almost entirely through employers, health plans, and pharmacy benefit managers rather than direct consumer sales. Its GLP-1 offering is unusual: rather than competing to be your prescriber, Omada built a behaviour-change companion programme designed to sit alongside whatever GLP-1 you are already taking — and it has published outcome data claiming better medication persistence as a result. This review evaluates Omada across access, programme design, evidence, GLP-1 handling, cost, and competitive fit.

Quick Takeaway:

• Virtual chronic care company distributing through employers, health plans, and PBMs
• Runs an Enhanced GLP-1 Care Track designed as a companion to medication rather than a replacement for it
• Has announced GLP-1 prescribing capability alongside its behaviour-change programme
• Published data claiming increased medication persistence and weight loss outcomes at 12 and 24 weeks
• Typically costs the member nothing when offered through a benefit

Looking for a Better Alternative?

If Omada is in your benefits package, take it — a free behavioural companion programme alongside your medication is strictly additive. If it is not available to you, CoreAge Rx is our top-rated favorite for GLP-1 weight loss therapy. CoreAge Rx combines competitive pricing with exceptional customer service, faster medication delivery, and more comprehensive support resources.

Why we recommend CoreAge Rx:

• Lower monthly costs than most competitors ($179–$399 range)
• Faster prescription approval (typically 12–24 hours)
• More extensive provider support included at no extra charge
• Better medication availability during shortages
• Higher patient satisfaction scores (4.7/5)

Omada is not sold directly to individuals in the way consumer platforms are. If you cannot access it through an employer or plan, you need a provider that sells to you.

New Patient Special: Save up to $200 on your first three months. Same-day prescription approval for qualifying patients. Rated 4.7/5 stars by verified customers. No insurance required.

What Is Omada Health?

Omada Health delivers virtual care for weight health, diabetes, hypertension, and musculoskeletal conditions, built on an evidence-based behaviour change programme with human care teams. It sells to employers, health plans, and pharmacy benefit managers, and has participated in PBM programmes that bring together benefit navigation, behavioural coaching, and access to clinically appropriate care for members using GLP-1s.

The company's strategic insight about GLP-1s is worth taking seriously. Real-world persistence on GLP-1 therapy is poor — a large share of patients discontinue within the first year, often because of side effects during titration, cost, or unmet expectations. Omada's Enhanced GLP-1 Care Track targets exactly that problem: high-touch support through dose escalation, side-effect mitigation, nutrition guidance, and exercise specialists to combat muscle loss.

How Omada Works

1. Access through your benefit. Eligibility comes via your employer, health plan, or PBM.
2. Enrol and get set up. Connected devices, app access, and assignment to a care team.
3. Care track selection. Members using or starting a GLP-1 can join the Enhanced GLP-1 Care Track.
4. Medication pathway. Omada has announced prescribing capability for anti-obesity medications, and also supports members prescribed elsewhere.
5. Ongoing programme. Coaching around titration, side effects, nutrition, and physical activity, with escalation to clinical support as needed.

Programme Content and Evidence

Important: Omada's published outcome data is company-generated and reported through its own channels rather than being independent randomised evidence. That does not make it wrong — persistence support plausibly improves outcomes, and the mechanism is credible — but it is company data about a company product, and should be read with that in mind.

The Physical Activity Specialist component addresses something most GLP-1 programmes neglect. Rapid weight loss on a GLP-1 includes lean mass loss, and resistance training is the primary countermeasure. A programme that assigns a specialist to build an exercise plan is doing something clinically substantive.

Check Omada GLP-1 Care Track

Behaviour change companion programme for GLP-1 members, typically available at no member cost through an employer or health plan benefit.

Eligibility, Providers, and Lab Requirements

Programme eligibility is determined by your employer, plan, or PBM. Clinical eligibility for anti-obesity medication follows standard criteria — BMI ≥30, or ≥27 with a weight-related comorbidity.

Because Omada operates inside benefit structures, its clinical and data governance standards are those of a payer-contracted provider rather than a consumer app. Medication, where prescribed, is filled under your pharmacy benefit.

Medication Fulfilment

Omada is not a compounding-supply platform. Where medication is involved, it is FDA-approved product filled through your pharmacy benefit. That means manufacturer-produced drug at your plan's copay — generally the cheapest and highest-quality route available to anyone with coverage.

Ongoing Support, Nutrition, and Coaching

This is the entire product, and it is genuinely strong:

• Rigorous GLP-1-specific training for the care delivery team
• Education on dose titration and what to expect at each step
• Side-effect mitigation strategies, which is the leading cause of early discontinuation
• Nutrition guidance built around adequate protein intake
• Exercise specialists focused on preserving muscle mass
• Support navigating medication access and coverage
• Skills practice designed to hold results after medication ends

Omada's framing — that the behavioural work is what makes the medication stick and what survives after it stops — is the correct clinical framing, and matches what our weight management evidence review describes.

Cancellation, Refunds, Insurance, and HSA/FSA

Benefit-delivered participation typically ends rather than being cancelled. There is normally no member charge to unwind.

Insurance and benefit integration is the entire distribution model. Where members incur out-of-pocket costs for medication, those generally qualify for HSA/FSA reimbursement.

Pros and Cons

Pros

• Typically free to the member through an employer or plan
• Purpose-built companion support for GLP-1 persistence — the right problem to solve
• Exercise specialists addressing muscle loss
• Structured side-effect management during titration
• FDA-approved medication through your pharmacy benefit
• Explicit focus on maintaining results after medication

Cons

• Not sold directly to individuals in most cases
• Outcome data is company-published rather than independent
• Programme availability and features vary by employer contract
• Less immediate and consumer-friendly than DTC platforms
• Prescribing capability varies by programme and market

Best Use Cases and Limitations

Best for: Anyone whose employer, health plan, or PBM offers Omada — particularly if you are already on a GLP-1 and struggling with side effects, adherence, or muscle loss.

Limitations: Individuals with no benefit access cannot generally buy this the way they buy a consumer subscription.

Alternatives to Omada Health

Frequently Asked Questions

How much does Omada Health cost?

Omada is distributed through employers, health plans, and pharmacy benefit managers, and typically costs the member nothing when offered as a benefit. It is not generally sold as a direct consumer subscription.

Does Omada prescribe GLP-1 medications?

Omada has announced prescribing and medication management capability for anti-obesity medications, including GLP-1s, within its behaviour change programme. Availability depends on your specific programme and market.

What is the Enhanced GLP-1 Care Track?

It is Omada's companion programme for members on GLP-1 therapy, providing high-touch care team support covering dose titration education, side-effect mitigation, nutrition guidance, and exercise support to help preserve muscle mass.

Does Omada actually improve outcomes?

Omada has published data reporting increased medication persistence and improved weight loss outcomes at 12 and 24 weeks for members in its Enhanced GLP-1 Care Track. This is company-published data rather than independent randomised evidence, though the mechanism — supporting patients through titration so they do not quit — is clinically plausible.

How do I find out if I have access to Omada?

Check your employer's benefits portal or your health plan's member materials. Omada is also included in some pharmacy benefit manager weight programmes.

Can I use Omada alongside a GLP-1 prescribed elsewhere?

Yes — that is the core design of the companion programme. It is built to support members on GLP-1 therapy regardless of who prescribed it.

Bottom Line

Omada is solving the problem that actually determines whether GLP-1 therapy works in the real world: whether people stay on it. Most consumer platforms optimise for getting you a prescription quickly. Omada optimises for you still being on that prescription in month nine, with your muscle mass intact and habits in place for when you stop.

Strengths: free through benefits, purpose-built persistence support, exercise specialists, structured side-effect management, FDA-approved medication through your benefit.

Drawbacks: benefit-gated access, company-published outcome data, and variability by employer contract.

Best for: benefit-eligible members, especially those already on a GLP-1.

Skip if: you have no benefit access and need someone to sell you a programme directly.

Check your benefits portal before paying for anything. Companion programmes like this are increasingly common, and the ones you already have access to are almost always the best value available.

No benefit access? CoreAge Rx: one all-in monthly price from $179–$399 including medication, provider messaging, and titration support. 12–24 hour approvals. Save up to $200 on your first three months.

Medical disclaimer: Informational only, not medical advice. GLP-1 receptor agonists are prescription medicines with real risks and contraindications. Consult a qualified healthcare professional before starting or changing treatment. Programme availability varies by employer and plan.

Sources: Omada Health published GLP-1 care track and resource centre pages; Omada investor news releases on GLP-1 prescribing and outcomes; industry reporting on PBM weight programmes.

Date reviewed: August 2026